Table 3.
Distribution of the primary endpoint and its components in subgroups defined by qualifying event and sex.
| Primary endpoint | Primary endpoint components | ||||
|---|---|---|---|---|---|
| CV death | MI | Stroke | Revasc | ||
| Intervention group | |||||
| Myocardial infarction/unstable angina | 117 (22.9) | 31 (26.5) | 30 (25.6) | 21 (17.9) | 35 (29.9) |
| Stroke/TIA | 97 (22.5) | 33 (34.0) | 8 (8.2) | 44 (45.4) | 12 (12.4) |
| Women | 81 (23.4) | 29 (35.8) | 13 (16.0) | 30 (37.0) | 9 (11.1) |
| Men | 133 (22.2) | 35 (26.3) | 25 (18.8) | 35 (26.3) | 38 (28.6) |
| Control group | |||||
| Myocardial infarction/unstable angina | 137 (27.0) | 37 (27.0) | 37 (27.0) | 19 (13.9) | 44 (32.1) |
| Stroke/TIA | 119 (27.2) | 25 (21.0) | 17 (14.3) | 65 (54.6) | 12 (10.1) |
| Women | 102 (29.7) | 23 (22.5) | 22 (21.6) | 37 (36.3) | 20 (19.6) |
| Men | 154 (25.5) | 39 (25.3) | 32 (20.8) | 47 (30.5) | 36 (23.4) |
Data are presented as N (%).
CV death, Cardiovascular death; MI, Myocardial infarction; Revasc, Cardiac revascularisation; TIA, Transient ischemic attack.